U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07070193) titled 'Longitudinal Cohort Study on Immune Thrombocytopenia Complicated With Acute Ischemic Stroke' on July 08.
Brief Summary: Immune thrombocytopenia (ITP) is an acquired bleeding disorder mediated by immune-related platelet destruction and impaired platelet production. Immune thrombocytopenia may increase the risk of cerebral infarction and represents a relatively uncommon etiology of acute ischemic stroke. This disease is associated with high disability and mortality rates, poses significant therapeutic challenges, and constitutes a serious threat to human health. Therefore, research on the diagnosis, treatment, and prognosis of ITP com...